Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Shares, $0.001 par value
Symbol
GRX on NYSE
Shares outstanding
15,447,782
Price per share
$9.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,647,549
Total reported value
$51,236,923
% of total 13F portfolios
0%
Share change
+218,035
Value change
+$1,958,321
Number of holders
54
Price from insider filings
$9.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 13% +7.9% $18,634,814 +$1,167,200 2,054,555 +6.7% Saba Capital Management, L.P. 16 Oct 2025
SIT INVESTMENT ASSOCIATES INC 5.4% $7,912,344 833,756 Sit Investment Associates, Inc. 30 Sep 2025

As of 30 Sep 2025, 54 institutional investors reported holding 5,647,549 shares of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX). This represents 37% of the company’s total 15,447,782 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Saba Capital Management, L.P. 13% 2,051,035 +3.8% 0.61% $18,602,887
SIT INVESTMENT ASSOCIATES INC 5.4% 833,756 +31% 0.15% $7,562,000
WELLS FARGO & COMPANY/MN 2.4% 369,670 -8.4% 0% $3,352,906
GAMCO INVESTORS, INC. ET AL 2% 312,226 -8.8% 0.03% $2,831,888
LPL Financial LLC 1.8% 285,653 +0.58% 0% $2,590,869
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC 1.8% 277,858 +15% 0.38% $2,520,172
MORGAN STANLEY 1.3% 193,960 +9.1% 0% $1,759,220
Aviance Capital Partners, LLC 1.1% 163,679 +1.1% 0.18% $1,484,567
STEPHENS INC /AR/ 0.78% 120,989 +10% 0.01% $1,097,370
CAPSTONE INVESTMENT ADVISORS, LLC 0.64% 99,441 0% 0.01% $901,930
AQR Arbitrage LLC 0.57% 87,814 -20% 0.02% $796,473
Traub Capital Management LLC 0.55% 85,585 -29% 0.77% $776,256
ABSOLUTE INVESTMENT ADVISERS, LLC 0.55% 85,122 0% 0.1% $772,057
Beacon Pointe Advisors, LLC 0.47% 72,100 -34% 0.01% $653,947
ROYAL BANK OF CANADA 0.42% 65,451 +1101% 0% $594,000
NewEdge Advisors, LLC 0.42% 64,121 +0.26% 0% $581,581
UBS Group AG 0.37% 56,692 -6% 0% $514,196
CSS LLC/IL 0.34% 52,671 -0.58% 0.03% $477,726
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.29% 44,181 -13% 0% $407,787
UHLMANN PRICE SECURITIES, LLC 0.23% 35,029 +15% 0.19% $317,731
Waverly Advisors, LLC 0.22% 33,465 -3.7% 0% $303,528
Janney Montgomery Scott LLC 0.22% 33,330 +0.13% 0% $302,000
RAYMOND JAMES FINANCIAL INC 0.2% 30,974 +84% 0% $280,935
Quarry LP 0.18% 27,469 0% 0.06% $249,144
Creative Planning 0.17% 26,839 -0.31% 0% $243,429

Institutional Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 109,233 $1,051,031 +$144,842 $9.63 6
2025 Q3 5,647,549 $51,236,923 +$1,958,321 $9.07 54
2025 Q2 5,429,514 $51,318,980 +$1,090,583 $9.45 58
2025 Q1 5,185,556 $52,270,856 +$718,989 $10.08 61
2024 Q4 5,245,659 $50,712,200 +$4,044,276 $9.64 66
2024 Q3 4,819,558 $52,659,347 +$3,042,302 $10.95 64
2024 Q2 4,590,471 $43,930,948 +$790,496 $9.58 67
2024 Q1 4,363,392 $44,668,783 +$1,244,686 $10.24 68
2023 Q4 10 $93 $9.30 1
2023 Q3 4,091,211 $35,091,899 +$854,713 $8.58 69
2023 Q2 3,989,072 $39,717,421 -$946,638 $9.96 70
2023 Q1 4,070,948 $41,067,254 +$556,474 $10.09 68
2022 Q4 4,166,131 $42,828,103 +$1,399,556 $10.28 65
2022 Q3 3,953,541 $37,571,883 -$1,544,134 $9.50 53
2022 Q2 4,110,366 $44,062,472 +$1,633,771 $10.72 55
2022 Q1 3,925,292 $50,315,564 -$4,018,680 $12.82 50
2021 Q4 4,108,467 $55,748,265 -$5,307,696 $13.57 51
2021 Q3 4,536,691 $59,927,581 -$4,117,179 $13.21 51
2021 Q2 4,894,945 $66,074,594 -$3,989,092 $13.50 59
2021 Q1 5,192,436 $64,694,548 -$843,692 $12.46 60
2020 Q4 5,288,748 $63,191,526 +$852,116 $11.95 57
2020 Q3 5,197,086 $53,600,454 -$1,789,930 $10.32 55
2020 Q2 6,530,934 $65,579,442 +$105,942 $10.04 54
2020 Q1 5,436,316 $47,230,381 +$462,487 $8.66 58
2019 Q4 5,385,437 $62,055,507 +$175,477 $11.52 56
2019 Q3 4,960,271 $51,669,013 -$238,156 $10.42 51
2019 Q2 4,982,311 $52,501,732 -$3,069,576 $10.54 51
2019 Q1 5,716,899 $60,081,384 -$612,446 $10.51 50
2018 Q4 5,845,246 $54,072,184 -$6,301,834 $9.25 49
2018 Q3 6,318,587 $69,503,490 +$471,599 $11.02 57
2018 Q2 6,303,697 $63,465,363 -$2,494,097 $10.02 57
2018 Q1 6,558,145 $62,337,418 +$1,055,442 $9.50 58
2017 Q4 6,445,398 $66,577,454 +$10,899,762 $10.32 53
2017 Q3 5,326,907 $53,788,000 +$4,529,108 $10.11 42
2017 Q2 128,820 $1,347,000 -$107,540 $10.45 7
2017 Q1 4,855,550 $48,505,000 +$3,261,388 $9.99 41
2016 Q4 4,531,045 $42,754,174 -$397,799 $9.43 42
2016 Q3 4,610,621 $47,997,002 +$442,482 $10.41 43
2016 Q2 4,567,993 $48,750,948 +$2,227,468 $10.67 39
2016 Q1 4,359,502 $43,024,000 -$1,871,305 $9.87 43
2015 Q4 4,537,798 $46,508,000 +$849,439 $10.25 41
2015 Q3 3,860,393 $37,424,000 -$619,524 $9.69 37
2015 Q2 4,510,606 $50,750,282 -$2,160,697 $11.25 33
2015 Q1 4,702,248 $52,940,284 +$223,779 $11.26 36
2014 Q4 4,508,812 $46,972,188 -$3,441,437 $10.42 35
2014 Q3 5,022,475 $49,800,129 +$16,208,221 $9.91 31
2014 Q2 3,332,200 $34,396,455 +$3,020,822 $10.32 31
2014 Q1 2,974,448 $30,763,179 +$3,366,925 $10.34 30